Capital Flow Monitor · Sponsors · CIK 2023557
Absco Therapeutics, Inc.
127 WESTERN AVENUE, ALLSTON, MA, 02134 · 314-917-7620
Biotechnology · Corporation· inc. DELAWARE true 2024
Fit score
—
Offering
$5.0M
Sold
$5.0M
% sold
100.0%
Investors
1
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2025-08-27 | D ·current | 506(b) | $5.0M | $5.0M | 100.0% | 1 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
- Stephen Linderman — Executive Officer / Director, Allston, MA
- Avik Som — Director, Allston, MA
-
Carlo Giovanni Traverso — Director, Allston, MA
1 other raise
- SYNTIS BIO, INC. $25.0M of $26.5M · 94.3%
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.